Who
Paul Bolno
Director
Company insider
Files Form 4 as: Director, Invivyd; President and CEO, Wave Life Sciences; Director, SQZ Biotechnologies Co.
In numbers
- Trades disclosed
- 79
- Buys
- 0
- Sells
- 22
- Bought
- $0
- Sold
- $15.9M
- Companies
- 3
- Companies where not an officer
- 2
- First trade
- 16 Jun 2016
- Last trade
- 19 May 2026
- Last filed
- 21 May 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 19 May 2026filed 21 May 2026 | IVVD Invivydoption or derivative · Biotechnology | SEC FORM 4 Code A | —32,876 at $0.00 | filing |
| 19 May 2026filed 21 May 2026 | IVVD Invivydoption or derivative · Biotechnology | SEC FORM 4 Code A | —32,876 at $0.00 | filing |
| 9 Feb 2026filed 11 Feb 2026 | WVE Wave Life SciencesBiotechnology | SEC FORM 4 Sold | $141K10,480 at $13.45 | filing |
| 9 Feb 2026filed 11 Feb 2026 | WVE Wave Life SciencesBiotechnology | SEC FORM 4 Sold | $141K10,480 at $13.45 | filing |
| 5 Feb 2026filed 11 Feb 2026 | WVE Wave Life SciencesBiotechnology | SEC FORM 4 Code A | —165,000 at $0.00 | filing |
| 5 Feb 2026filed 11 Feb 2026 | WVE Wave Life Sciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —1,000,000 at $0.00 | filing |
| 5 Feb 2026filed 11 Feb 2026 | WVE Wave Life Sciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —1,000,000 at $0.00 | filing |
| 5 Feb 2026filed 11 Feb 2026 | WVE Wave Life SciencesBiotechnology | SEC FORM 4 Code A | —165,000 at $0.00 | filing |
| 22 Sep 2025filed 24 Sep 2025 | IVVD Invivydoption or derivative · Biotechnology | SEC FORM 4 Code A | —100,000 at $0.00 | filing |
| 22 Aug 2025filed 26 Aug 2025 | WVE Wave Life SciencesBiotechnology | SEC FORM 4 Sold | $2.2M217,351 at $10.10 | filing |
| 7 Mar 2025filed 7 Mar 2025 | WVE Wave Life Sciencesoption or derivative · Biotechnology | SEC FORM 4 Code M | —120,966 at $0.00 | filing |
| 7 Mar 2025filed 7 Mar 2025 | WVE Wave Life Sciencesoption or derivative · Biotechnology | SEC FORM 4 Code M | —48,059 at $0.00 | filing |
| 7 Mar 2025filed 7 Mar 2025 | WVE Wave Life SciencesBiotechnology | SEC FORM 4 Code M | $419K169,025 at $2.48 | filing |
| 7 Mar 2025filed 7 Mar 2025 | WVE Wave Life SciencesBiotechnology | SEC FORM 4 Sold | $1.6M169,025 at $9.57 | filing |
| 4 Feb 2025filed 6 Feb 2025 | WVE Wave Life Sciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —1,000,000 at $0.00 | filing |
| 4 Feb 2025filed 6 Feb 2025 | WVE Wave Life SciencesBiotechnology | SEC FORM 4 Code A | —121,000 at $0.00 | filing |
| 25 Nov 2024filed 27 Nov 2024 | WVE Wave Life Sciencesoption or derivative · Biotechnology | SEC FORM 4 Code M | —50,000 at $0.00 | filing |
| 25 Nov 2024filed 27 Nov 2024 | WVE Wave Life SciencesBiotechnology | SEC FORM 4 Code M | $124K50,000 at $2.48 | filing |
| 25 Nov 2024filed 27 Nov 2024 | WVE Wave Life SciencesBiotechnology | SEC FORM 4 Sold | $750K50,000 at $15.00 | filing |
| 15 Nov 2024filed 15 Nov 2024 | WVE Wave Life SciencesBiotechnology | SEC FORM 4 Sold | $734K51,234 at $14.32 | filing |
News
Wave Life Sciences Third Quarter 2026 Financial Results Scheduled for October 27, 2026WVE · manilatimes.net · 20 Oct 2026Wave Life Sciences to Host Virtual Research Day on Wednesday, November 4, 2026WVE · manilatimes.net · 19 Oct 2026WAVE Life Sciences (NASDAQ:WVE) and Alumis (NASDAQ:ALMS) Head to Head ComparisonWVE · dailypolitical.com · 18 Oct 2026
0 headlines in the last 90 days name Paul Bolno; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.